Back

QT prolongation and conduction disturbances during chemotherapy

17 March 2019 (16:30 - 16:52)
Organised by:
Congress Presentation Part of: Cardio-oncology - A new frontier for arrhythmia specialists Pathophysiology and Mechanisms EHRA Premium Access EHRA 2019

About the speaker

Photo
Professor Christian Sticherling

University Hospital Basel, Basel (Switzerland)

3 More presentations in this session

Presentation thumbnail
Interplay of atrial fibrillation, heart failure and chemotherapy
Doctor A. Lyon (London, GB)
Slides Video
Presentation thumbnail
Management of patients with CIEDs undergoing radiotherapy
Professor G. Boriani (Modena, IT)
Presentation thumbnail
Atrial fibrillation during chemotherapy - Assessing the risk-benefit ratio for anticoagulation
Professor J. Oldgren (Uppsala, SE)
Slides Video

Access the full session

Session thumbnail
Cardio-oncology - A new frontier for arrhythmia specialists

The Event

Event poster

EHRA 2019

17 March 2019 16:30 CET
You may be interested in
thumbnail
Congress Presentation
Diagnosis and management of acute and subacute CVDs in patients with active cancer.
27 August 2022
thumbnail
Congress Presentation
Incidence of drug-drug interactions of QT-prolonging drugs in an onco-hematological outpatient
27 August 2022
thumbnail
Congress Presentation
Monitoring of anthracycline-induced cardiotoxicity in the treatment of haematological malignancies, a local perspective
29 June 2021
thumbnail
Congress Presentation
The delicate balance of permissive cardiotoxicity strategy in cancer-related cardiac dysfunction at a tertiary Centre: a comparative analysis
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources